KFF (@KFF) header
KFF (@KFF) profile picture

The independent source for health policy research, polling, and news.

San Francisco | Washington DC
Joined October 2009
Photo by KFF (@KFF)Photo by KFF (@KFF)Photo by KFF (@KFF)Photo by KFF (@KFF)Photo by KFF (@KFF)Photo by KFF (@KFF)Photo by KFF (@KFF)Photo by KFF (@KFF)Photo by KFF (@KFF)Photo by KFF (@KFF)
The U.S. had the highest maternal mortality rate among wealthy nations in 2024 — even though economic prosperity is correlated with lower maternal deaths: on.kff.org/42I5t4R
183
The projected average monthly premium of $51 for Medicare Part D stand-alone drug plans in 2027 is more than 5X higher than the drug coverage premium in Medicare Advantage plans that offer Part D coverage, which is projected to average $9/month in 2027. on.kff.org/3W8kgFz
2
291
The average monthly premium for Medicare Part D coverage in stand-alone prescription drug plans (PDPs) will increase to $51 in 2027, up 50% from $34 in 2026, if current enrollees don’t switch into lower-premium plans during the open enrollment period. on.kff.org/3W8kgFz
3
2
2
424
KFF retweeted
NEWS: One of Trump's key campaign-trail boasts is that he's cut drug prices. The GOP "should win just on this," he says. Yet @KFF found that premiums for Medicare stand-alone drug plans are set to jump 50 PERCENT next year, on average. By @philgalewitz kffhealthnews.org/medicare/m…
4
19
3
18
3,716
New: Medicare Part D Stand-Alone drug plan premiums will rise 50% if enrollees stay in their current plans and don't switch to lower premium coverage.
1
5
2
6
1,473
What will the results of the midterm elections mean for health care going forward? At noon ET on 11/5, join KFF experts and @KFFHealthNews journalists for a special post-election discussion and live taping of the #WTHealth podcast. Register for the virtual event here: on.kff.org/4iK9qy6
1
1
349
About 3.1 million people in Medicare Advantage prescription drug plans will see their plans terminated at the end of 2026. Another 1.4 million Medicare Advantage enrollees are in a plan that is consolidating with another plan offered by the same insurer: on.kff.org/4zXlfXM
2
1
2
419
In @JAMAHealthForum, @Larry_Levitt notes that although Medicare-for-All plans offer more generous benefits than Medicare, it could end up looking more like Medicare if it underwent a serious national debate about the tradeoffs involved to implement it: bit.ly/4yZHeMU
1
2
1
2
753
What will the midterm election results mean for health care? Join KFF experts and @KFFHealthNews journalists at noon ET on 11/5 for a special post-election briefing offering analysis, insights and answers to audience questions. Sign up to attend the virtual event: on.kff.org/4iK9qy6
521
How much do health care costs influence voter motivation? KFF’s @Mollybrodie and Liz Hamel discuss what our latest polling says about the connection between health care affordability, economic concerns, and voter enthusiasm ahead of the midterms. Explore the findings: on.kff.org/4zgJv6z
1
437
New work requirements in Medicaid go into effect in two months.
1
11
1
20
2,017
Medicare-for-All promises more generous benefits than the existing Medicare program, with no premiums or deductibles, though a serious debate about tradeoffs likely would result in compromises, writes @Larry_Levitt in @JAMAHealthForum: bit.ly/4yZHeMU
2
628
A drawn-out legislative debate over Medicare for All would mean furious lobbying by the health care industry and likely compromises. A Medicare for All system could end up looking more like Medicare today than the proposals introduced in Congress. jamanetwork.com/journals/jam…
4
1
3
3,271
Advocates for a national health plan call it Medicare for All, drawing on the longstanding trust in the Medicare program. But, the most prominent Medicare for All plans envision coverage much more comprehensive and affordable for patients than Medicare today.
7
8
9
51
9,727
In this week’s episode, Dr. Sarah Teichmann — co-founder of the Human Cell Atlas and chair in Stem Cell Medicine at the University of Cambridge — explains why seeing biology at the level of individual cells could reshape how researchers understand disease and develop treatments: on.kff.org/3WbIbDV
1
388
About 1.2 million enrollees in Medicare stand-alone prescription drug plans (PDPs) will see their plan terminated on 12/31. Most are in one plan, the SilverScript Choice PDP sponsored by CVS Health, which is being terminated in 13 PDP regions for 2027: on.kff.org/4zXlfXM
3
1
5
627
What will the results of the midterm elections mean for health care going forward? At noon ET on 11/5, join KFF experts and @KFFHealthNews journalists for a special post-election discussion and live taping of the #WTHealth podcast. Register for the virtual event here: on.kff.org/4iK9qy6
3
1
720
A KFF analysis finds that 4.3 million Medicare beneficiaries will have their Part D stand-alone prescription drug plan or Medicare Advantage plan w/ drug coverage terminated on Dec. 31. Enrollees can make coverage changes for 2027 during open enrollment: on.kff.org/4zXlfXM
2
5
2
6
808
During his Victor J. Dzau Keynote Address at the National Academy of Medicine’s 2026 Annual Meeting, KFF’s @DrewAltman spoke about the challenges ahead in health policy, and where chronic illness fits. Read the full remarks: on.kff.org/47G64pM
1
452